Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FP0UD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,385
Award facts
- Contract value 100% obligated
- $14,384.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injectors with a ceiling value of $14,384.67. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the delivery order is scheduled for ultimate completion by October 30, 2025. This award is issued under a larger Indefinite Delivery Contract (IDC) framework with the DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical product deliveries through the DLA Medical Supply Chain, including brand-name and generic medications across multiple therapeutic domains. The Zepbound product awarded under this delivery order supports DLA's mission to provide pharmaceutical commodities to Defense Health Agency customers, the U.S. Coast Guard, and other federal healthcare systems. The DLA is planning to establish multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts in the coming period, with the intent to award to multiple contractors, further demonstrating the strategic importance of vendors like AmerisourceBergen to the federal healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB26FP0UD?
SPE2DB26FP0UD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FP0UD worth?
The government has obligated $14,385 on SPE2DB26FP0UD.
Is contract SPE2DB26FP0UD an order under another contract?
Yes. SPE2DB26FP0UD is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB26FP0UD competed?
The extent of competition for SPE2DB26FP0UD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award